Trials / Conditions / Squamous Cell Carcinoma of Anal Canal
Squamous Cell Carcinoma of Anal Canal
3 registered clinical trials studyying Squamous Cell Carcinoma of Anal Canal — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven NCT04429542 | Bicara Therapeutics | Phase 1 |
| Completed | A Study of INCMGA00012 in Squamous Carcinoma of the Anal Canal Following Platinum-Based Chemotherapy (POD1UM-2 NCT03597295 | Incyte Corporation | Phase 2 |
| Terminated | Nimotuzumab With Radiotherapy in the Treatment of Anal Canal Cancers NCT01382745 | Dr. Te Vuong | Phase 2 |